Skip to main content
Click to learn more


Inflammatory bowel disease (IBD) is a chronic condition with fluctuating activity that requires ongoing monitoring. At University Hospitals Birmingham (UHB), they saw an opportunity to improve the efficiency and lower the cost of their traditional approach. This involved scheduling specialist follow-ups every six months, resulting in unnecessary travel and missed workdays due to redundant hospital visits for well-controlled patients, while providing inadequate care for patients who required closer monitoring. This model places a load on clinicians and the healthcare system, which may lead to misallocated resources and higher long‑term treatment costs due to delayed interventions.


Impact


2k
Patients onboarded
30%
Improvement in patient disease activity
~20%
Reduction of cost
Click to learn more


Chronic heart failure affects an estimated 64 million people worldwide and is associated with significant morbidity, mortality, and high healthcare expenditures. Hospital readmission rates within 30 days are notably elevated for heart failure patients compared to other chronic conditions, and inpatient costs per patient tend to be substantially higher when readmissions occur. Overall, these factors contribute to a considerable economic burden on the healthcare system.


Impact


~50%
Reduction in the number of 30-day readmissions
~$1,000
Cost savings per patient per month
Increase
In clinical efficiency
Click to learn more


Hypertension, also known as high blood pressure, is a common condition where the blood pressure is persistently elevated. It affects an estimated 1.28 billion adults aged between 30 and 79 worldwide, yet it is estimated that only 21% of those with the condition have it under control, and nearly half remain unaware of their condition, resulting in preventable strokes, heart attacks, and emergency admissions that overwhelm hospital capacity and significantly drive up operational costs.


Impact


~38%
Reduction in the number of hospital admissions
~50%
Decrease in heart attack and stroke occurrence (compared to usual care and self-monitoring alone)
Reduction
In the number of in-person visits
Click to learn more


Chronic hepatitis B and C affect hundreds of millions globally, with an estimated 300 million people affected by this, yet screening uptake remains suboptimal. In fact, only around 9% of individuals with hepatitis B and 20% of those with hepatitis C are aware of their infection status. Untreated infections can progress to liver cirrhosis and hepatocellular carcinoma, conditions that are not only more expensive to manage but also more complex, requiring intensive, long-term care that places considerable strain on healthcare budgets and resources.


Impact


20-30%
Increase in number of patients screened
20%
Reduction in time spent on administrative tasks
Faster
Clinical workflows than ever
Click to learn more


NHS providers, including Moorfields Eye Hospital and University Hospitals Birmingham, are struggling with lengthy ophthalmology outpatient backlogs, driven largely by the high volume of diabetic patients who require regular specialist monitoring. Current workflows are labor‑intensive and rely on scarce, high‑cost ophthalmologists, leading to prolonged wait times that increase the risk of preventable complications such as irreversible vision loss.


Impact


32%
Reduction of costs
47%
Increased throughput of patients
80%
Wait time targets achieved
Click to learn more


In recent years pressure on hospital beds has intensified. Chronic respiratory diseases are a major contributor to stretched secondary care capacity and unplanned readmissions. Although clear, evidence-based guidelines exist, inconsistent monitoring and delayed detection of exacerbations often result in avoidable acute episodes. These challenges leave clinicians in a difficult position, as they cannot safely discharge patients without confidence that recovery can be reliably supported and monitored outside the hospital. Consequently, this contributes to higher 30-day readmission rates and treatment costs that can be three to five times greater than those associated with earlier intervention.


Impact


20%
Reduction in hospital readmissions
~$2500
In cost savings per patient compared to traditional care
18%
Increase in inhaler-adherence rate by using digital support